Amyotrophic lateral sclerosis: Recent advances in understanding disease mechanisms

Journal of Neuropathology and Experimental Neurology

Volumn 55, Issue 7, 1996, Pages 747-757

  De Belleroche, J ^a   Orrell, R W ^a   Virgo, L ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; GLUTAMIC ACID; GLYCINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

AMINO ACID TRANSPORT; AMYOTROPHIC LATERAL SCLEROSIS; CYTOSKELETON; ENZYME ACTIVITY; FAMILIAL DISEASE; GENE LOCUS; GENE MUTATION; GENETIC LINKAGE; HUMAN; LIPID PEROXIDATION; NERVE DEGENERATION; NEUROFILAMENT; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0030014299     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199607000-00001     Document Type: Review

References (60)

1. Goonetilleke A, de Belleroche J, Guiloff RW. Motor neurone disease. In: Tipton K, ed. Essays in biochemistry. Portland Press: London, 1994:27-45
2. Williams DB. Familial amyotrophic lateral sclerosis. In: De Jong JMBV, ed. Handbook of clinical neurology, Vol. 15. Elsevier: 1991: 241-51
3. Siddique T, Figlewicz DA, Pericak-Vance MA, et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med 1991;324:1381-84
4. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-63
5. Deng H-X, Hentati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 1993;261:1047-51
6. Fridovich I. Superoxide radical: An endogenous toxicant. Ann Rev Pharmacol Toxicol 1983;23:239-57
7. Liu TH, Beckmann JS, Freeman BA, Hogan EL, Hsu CY. Polyethylene glycoconjugated superoxide dismutase and catalase reduce ischaemic brain injury. Am J Physiol 1989;256:H589-93
8. Imaizumi S, Woolworth V, Fishman RA, Chan PH. Liposome entrapped superoxide dismutase reduces cerebral infarction in cerebral ischaemia in rats. Stroke 1990;21:1312-17
9. King A, Houlden H, Hardy J, Lane R, Chancellor A, de Belleroche J. Absence of linkage between chromosome 21 loci and familial amyotrophic lateral sclerosis. J Med Genet 1993;30:318
10. Rosen DR, Sapp P, O'Regan J, et al. Genetic linkage analysis of familial amyotrophic lateral sclerosis using human chromosome 21 microsatellite DNA markers. Am J Med Genet 1994;51:61-69
11. de Belleroche J, Orrell R, King A. Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): A review of current developments. J Med Genet 1995;32:841-47
12. Levanon D, Lieman-Hurwitz J, Dafni N, et al. Architecture and anatomy of the chromosomal locus in human chromosome 21 encoding the Cu/Zn superoxide dismutase. EMBO J 1985;4:77-84
13. Esteban J, Rosen DR, Bowling AC, Sapp P, McKenna-Yasek D. Identification of two novel mutations and a new polymorphism in the gene for Cu/Zn superoxide dismutase in patients with amyotrophic lateral sclerosis. Human Mol Genet 1994;3:997-98
14. Hosler BA, Nicholson GA, Sapp PC, et al. Three novel mutations and two polymorphisms in the gene for Cu/Zn superoxide dismutase in familial amyotrophic lateral sclerosis. 1996, submitted
15. Enayat ZE, Orrell RW, Claus A, Ludolph A, Powell PN, Leigh PN, de Belleroche J. Two novel mutations in the gene for copper zinc superoxide dismutase in UK families with amyotrophic lateral sclerosis. Hum Molec Genet 1995;4:1239-40
16. Orrell RW, de Belleroche J, Marklund SL, Bowe F, Hallewell RA. A novel SOD-1 mutant and ALS. Nature 1995;374:504-5
17. Orrell RW, King AW, Hilton DA, Campbell MJ, Lane RJM, de Belleroche J. Familial amyotrophic lateral sclerosis with a point mutation of SOD-1: Intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiat 1995;59:266-70
18. Yulug IG, Katsanis N, de Belleroche J, Collinge J, Fisher EMC. An improved protocol for the analysis of SOD1 gene mutations and a new mutation in exon 4. Hum Molec Genet 1995;4:1239-40
19. Nakano R, Sato S, Inuzuka T et al. A novel mutation in Cu/Zn superoxide dismutase gene in Japanese familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 1994;200:695-703
20. Jones CT, Swingler RJ, Brock DJH. Identification of a novel SOD-1 mutation in an apparently sporadic amyotrophic lateral sclerosis patient and the detection of IIe113Thr in three others. Human Mol Genet 1994;3:649-50
21. Tsuda T, Munthasser S, Fraser PE, et al. Analysis of the functional effects of a mutation in SOD1 associated with familial amyotrophic lateral sclerosis. Neuron 1994;13:727-36
22. Aoki M, Ogasawara M, Matsubara Y, Narisawa K, Nakamura S, Itoyama Y, Abe K. Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in Cu/Zn superoxide dismutase gene: A possible new subtype of familial ALS. J Neurol Sci 1994; 126:77-83
23. Elshafey A, Lanyon WG, Connor JM. Identification of a new missense point mutation in exon 4 of the Cu/Zn superoxide dismutase (SOD-1) gene in a family with amyotrophic lateral sclerosis. Human Mol Genet 1994;3:363-64
24. Ogasawara M, Matsubara Y, Narisawa K, Aoki M, Nakamura S, Itoyama Y, Abe K. Mild ALS in Japan associated with novel SOD mutation. Nature Genet 1993;5:323-24
25. Jones CT, Shaw PJ, Chari G, Brock DJH. Identification of a novel exon 4 SOD1 mutation in a sporadic amyotrophic lateral sclerosis patient. Mol Cell Probes 1994;8:329-30
26. Orrell RW, Habgood J, Rudge P, Lane RJM, de Belleroche J. Difficulties in distinguishing sporadic from familial forms of amyotrophic lateral sclerosis. Ann Neurol 1996;39:810-18
27. Orrell RW, de Belleroche J. Superoxide dismutase and ALS. The Lancet 1994;344:1651-52
28. Borchelt DR, Lee MK, Slunt HS, et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 1994;91:8292-96
29. Nishida CR, Gralla EB, Valentine JS. Characterization of three yeast copper-zinc superoxide dismutase mutants analogous to those encoded for in familial amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 1994;91:9906-10
30. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science 1994;264:1772-75
31. Orrell RW, de Belleroche J, Marklund SL, Bowe F, Hallewell RA. Toxic mutants in Charcot's sclerosis. Nature 1995;378:343
32. Yang G, Chan PH, Chen J, Carlson E, Chen SF, Weinstein P, Epstein CJ, Camii H. Human copper-zinc superoxide dismutase transgenic mice are highly resistant to reperfusion injury after focal cerebral ischaemia. Stroke 1994;25:165-70
33. Chan PH, Kamii H, Yang G, Gafni J, Epstein CJ, Carlson E, Reola L. Brain infarction is not reduced in SOD-1 transgenic mice after permanent focal cerebral ischaemia. NeuroReport 1993;5:293-96
34. Rothstein JD, Bristol LA, Hosler B, Brown RH, Kuncl RW. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal motor neurones. Proc Natl Acad Sci USA 1994;91:4155-59
35. Bergeron C, Muntasser S, Somerville MJ, Weyer L, Percy ME. Superoxide dismutase mRNA levels are increased in sporadic amyotrophic lateral sclerosis. Brain Res 1994;659:272-76
36. Wiedau-Pazos M, Goto JJ, Rabizadeh S, Gralla EB, Roe JA, Lee MK, Valentine JS, Bredesent DE. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science 1996;271:515-18
37. Gurney ME, Cutting FB, Zhai P, Doble A, Taylor CP, Andrus PK, Hall ED. Benefit of vitamin E, riluzole and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann Neurol 1996;39:147-57
38. Rouleau GA, Clark AW, Rooke K, Pramatarova A, Krizus A, Suchowersky O, Julien J-P, Figlewicz D. SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurol 1996;39:128-31
39. Figlewicz DA, Krizus A, Martinole M, et al. Variants of the human heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Human Mol Genet 1994;3:1757-61
40. Dal Canto MC, Gurney ME. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS). Brain Res 1995;676: 25-40
41. Uchino M, Ando Y, Tanaka Y, Nakamura T, Uyama E, Mita S, Murakami T, Ando M. Decrease in Cu/Zn- and Mn-superoxide dismutase activities in brain and spinal cord of patients with amyotrophic lateral sclerosis. J Neurol Sci 1995; 127:61-67
42. Shibata N, Hirano A, Kobayashi M, et al. Cu/Zn superoxide dismutase-like immunoreactivity in Lewy body-like inclusions of sporadic amyotrophic lateral sclerosis. Neurosci Lett 1994:179:149-52
43. Orrell RW, King AW, Lane RM, de Belleroche J. Investigation of a null mutation in the CNTF gene in familial amyotrophic lateral sclerosis. J Neurol Sci 1995;132:126-28
44. Li Y, Huang T-T, Carlson EJ, et al. Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nature Genetics 1995;11:376-81
45. Mui S, Rebeck GW, McKenna-Yasek D, Hyman BT, Brown RH. Apolipoprotein E ∈4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann Neurol 1995;38:460-63
46. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med 1992;326:1464-68
47. Rothstein JD, Van Kammen M, Levey AI, et al. Selective loss of glial transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol 1995;38:73-84
48. Lane RJM, Bandopadhyay R, de Belleroche J. Abnormal glycine metabolism in motor neurone disease: Studies on plasma and cerebrospinal fluid. J Roy Soc Med 1993;86:501-6
49. Virgo L, de Belleroche J. Induction of the immediate early gene c-jun in human spinal cord in amyotrophic lateral sclerosis with concomitant loss of NMDA receptor NR-1 and glycine transporter mRNA. Brain Res 1995;676:196-204
50. 3H]MK-801. Brain Res 1994;637:297-302
51. Virgo L, de Belleroche J, Rossi M, Steiner TJ. Characterization of the distribution of choline acetyltransferase messenger RNA in human spinal cord and its depletion in motor neurone disease. J Neurol Sci 1992;112:126-32
52. Collaço-Moraes Y, Aspey BS, de Belleroche J, Harrison MJ. Focal ischaemia causes an extensive induction of immediate early genes that are sensitive to MK-801. Stroke 1994;25:1855-61
53. Collaço-Moraes Y, de Belleroche J. Differential temporal patterns of expression of immediate early genes in the cerebral cortex induced by intracerebral excitotoxic injection: Sensitivity to MK-801 and dexamethasone. Neuropharmacol 1995;34:521-31
54. Herdegen T, Fiallos-Estrada CE, Schmid W, Bravo R, Zimmermann M. The transcription factors c-JUN, JUN-D and CREB but not FOS and KROX-24 are differentially regulated in axotomised neurons following transection of rat sciatic nerve. Mol Brain Res 1992;14: 156-65
55. Jenkins R, O'Shea R, Thomas KL, Hunt SP. c-jun expression in substantia nigra neurons following striatal 6-hydroxydopamine lesions in the rat. Neuroscience 1993;53:447-55
56. Anderson AJ, Cummings BJ, Cotman CW. Increased immunoreactivity for Jun- and Fos-related proteins in Alzheimer's disease; association with pathology. Exp Neurol 1994;125:286-95
57. Bensimon G, Lasomblez L, Meininger V and the ALS/Riluzole Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994;330:585-91
58. Lafon-Cazal M, Pietri S, Culcasi M, Bockaert J. NMDA-dependent superoxide production and neurotoxicity. Nature 1993;364:535-37
59. Ikeda K, Kinoshita M, Iwasaki Y, Tagaya N, Shiojima T. Lecithinized superoxide dismutase retards wobbler mouse motoneuron disease. Neuromuscular Disord 1995;5:383-90
60. Smith RA, Balis FM, Ott KH, Elsberry DD, Sherman MR, Saifer MG. Pharmacokinetics and tolerability of ventricularly administered superoxide dismutase in monkeys and preliminary clinical observations in familial ALS. J Neurol Sci 1995;129:Suppl 13-18